Preparation and characterization of erythrocyte membrane cloaked PLGA/arsenic trioxide nanoparticles and evaluation of their in vitro anti-tumor effect

Arsenic trioxide (ATO) is used for acute promyelocytic leukemia (APL) that is resistant to all-trans-retinoic acid, but its direct intravenous injection sometimes induces severe toxic side effects. Here, we developed a delivery system of red blood cell membrane (RBCM) cloaked poly (lactic-co-glycoli...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Jing, Liu, Geyi, Lian, Yumei, Kamal, Zul, Que, Xiao, Qiu, Yujiao, Qiu, Mingfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2018
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080777/
https://www.ncbi.nlm.nih.gov/pubmed/35541656
http://dx.doi.org/10.1039/c8ra01417e

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080777/
https://www.ncbi.nlm.nih.gov/pubmed/35541656
http://dx.doi.org/10.1039/c8ra01417e

Ejemplares similares